To focus on Prevention, Prediction and Personalization of management of the risk of esophageal adenocarcinoma in Barrett's esophagus patients, this project will examine some of the earliest processes contributing to neoplastic progression in BE: genomic damage, genomic instability, and the roles of telomere shortening and telomerase reactivation. We hypothesize that neoplastic evolution in BE begins with inflammation-induced DNA damage, followed by telomere shortening and chromosomal instability, and we have shown that these are all early event in the evolution of BE. While DNA damage, telomere attrition and chromosomal instability may initially initiate checkpoint-suppression of progression to cancer, escape through reactivation of telomerase is almost always required before cancer in BE.
In Aim 1, we will quantitate telomere shortening and reactivation of telomerase in BE patients and we will perform prospective longitudinal analyses of our BE surveillance cohort to define their utility in predicting an individual patient's cancer risk. We also believe that understanding these mechanisms will contribute to new and better strategies for chemoprevention, and demonstrate this in our cohort by showing an interaction of telomere length and NSAIDs in modulating cancer risk. Secondly, we hypothesize that genetic instability at chromosomal fragile sites is a sensitive marker of genotoxic stress and genetic damage to the esophageal epithelium. Analysis of copy changes and loss of heterozygosity at fragile sites has the features required to be a practical clinical biomarker, and therefore we will determine its predictive value for cancer risk assessment in prospective study and longitudinal follow-up of BE patients. Together, Aims 1 and 2 have the potential to define clinical biomarkers of BE cancer risk that are based on basic underlying mechanisms of genomic instability that facilitate neoplastic evolution. Strong collaborations with Projects 1 and 2 and Cores B and C help to define relationships to other molecular markers, host and environmental factors and chemoprevention strategies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA091955-10
Application #
8293345
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
2013-06-30
Budget Start
2011-07-01
Budget End
2013-06-30
Support Year
10
Fiscal Year
2011
Total Cost
$311,329
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Barry, Peter; Vatsiou, Alexandra; Spiteri, Inmaculada et al. (2018) The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer. Clin Cancer Res 24:4763-4770
Dong, Jing; Levine, David M; Buas, Matthew F et al. (2018) Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Clin Gastroenterol Hepatol 16:1598-1606.e4
Xia, Li Charlie; Ai, Dongmei; Lee, Hojoon et al. (2018) SVEngine: an efficient and versatile simulator of genome structural variations with features of cancer clonal evolution. Gigascience 7:
Galipeau, Patricia C; Oman, Kenji M; Paulson, Thomas G et al. (2018) NSAID use and somatic exomic mutations in Barrett's esophagus. Genome Med 10:17
Martinez, Pierre; Mallo, Diego; Paulson, Thomas G et al. (2018) Evolution of Barrett's esophagus through space and time at single-crypt and whole-biopsy levels. Nat Commun 9:794
Dong, Jing; Buas, Matthew F; Gharahkhani, Puya et al. (2018) Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. Gastroenterology 154:1273-1281.e3
Chowell, Diego; Napier, James; Gupta, Rohan et al. (2018) Modeling the Subclonal Evolution of Cancer Cell Populations. Cancer Res 78:830-839
Maley, Carlo C; Aktipis, Athena; Graham, Trevor A et al. (2017) Classifying the evolutionary and ecological features of neoplasms. Nat Rev Cancer 17:605-619
Cheng, Yichen; Dai, James Y; Paulson, Thomas G et al. (2017) Quantification of Multiple Tumor Clones Using Gene Array and Sequencing Data. Ann Appl Stat 11:967-991
Reid, Brian J (2017) Genomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective. Cell Mol Gastroenterol Hepatol 3:359-366

Showing the most recent 10 out of 131 publications